US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (255)
  • Diseases & Conditions (3957)
  • Drug Delivery (279)
  • Therapeutic Area (7153)
  • Vaccines (720)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
9/6/2014 | published by: Visiongain
... of kinase inhibitors? Now get the latest analysis for those cancer treatments. There you explore developments, other trends, results, opportunities and revenue forecasts. Visiongain’s new report shows you what’s possible for drugs using protein kinase ...  |  read more...
USD 2,986
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
... Biosimilars, Generics & Vaccines” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle ...  |  read more...
USD 2,000
Pharmaceutical Preparation Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition]
7/29/2014 | published by: Supplier Relations US, LLC
... inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 175-page report includes the most recent information on ...  |  read more...
USD 799
Biological Product (except Diagnostic) Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition]
7/29/2014 | published by: Supplier Relations US, LLC
... shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 170-page report includes the most recent ...  |  read more...
USD 599
Medicinal and Botanical Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition]
7/29/2014 | published by: Supplier Relations US, LLC
... and pricing, and trends during the current environment, including the output and shipment changes over the past months. At 175 pages with over 150 charts and tables, the report covers topics such as current macroeconomic ...  |  read more...
USD 599
Pharmaceutical Blister Packaging - Global Markets, Economics, Environmental Impact, Technology, and Participants 2014 to 2018
7/25/2014 | published by: Allied Development Corp
... of technology, economic and environmental forces, market drivers and trends, market projections, and industry participants. The Technology section analyses packaging materials, structures, processes, and machinery. The Economic/Environmental section examines bottom web manufacturing and provides quantitative ...  |  read more...
USD 4,495
Latest Guidebook for Conducting Pharma Clinical Trials - China: From Regulations to Practice (2014 Edition)
7/25/2014 | published by: Access China Management Consulting Ltd.
... of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. ...  |  read more...
USD 1,495
Pharmaceuticals and Healthcare Report - Malaysia - Q3 2014
7/23/2014 | published by: Business Monitor International
... However, wehave downgraded Malaysia's pharmaceutical sales forecast due to a slowdown in pharmaceutical trade in2013. The country's slower economic growth in 2014, coupled with the fact that investment in thepharmaceuticals sector will take longer than ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Sri Lanka - Q3 2014
7/23/2014 | published by: Business Monitor International
... and the government focused onimproving the domestic pharmaceutical sector. We therefore expect that pharmaceutical and healthcaresector growth will outpace economic growth over the five-year forecast period. Improved relations withIndia, after the country abstained from voting ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Czech Republic - Q3 2014
7/23/2014 | published by: Business Monitor International
... the healthcare system willcontinue to impact demand within the Czech Republic. We also believe the new centre-left coalitiongovernment poses downside risk to our forecasts given its commitment to containing healthcare costs andimproving access to medicines. ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Denmark - Q3 2014
7/23/2014 | published by: Business Monitor International
... for its wellestablished,albeit relatively small, pharmaceutical market. The robust demand for healthcare services willsee the Danish government continue to adapt strategies and cost-containment measures to manageincreasing healthcare costs. Despite this, we believe the country's high ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - United Arab Emirates - Q3 2014
7/23/2014 | published by: Business Monitor International
... aiming to introduce comprehensive health insurance throughoutthe country, allowing businesses to shoulder much of the cost of this expanded coverage, the governmentwill gradually contribute less to the country's healthcare spending. Between 2013 and 2018, we ...  |  read more...
USD 1,295
Global Retinal Vein Occlusion Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... AG, F. Hoffmann-La Roche Ltd., Novartis AG and Regeneron Pharmaceuticals Inc. Other prominent vendors in the market are: Alimera Sciences, Bristol-Myers Squibb, NicOx, Santen Pharmaceutical and Valeant Pharmaceuticals. Commenting on the report, an analyst from ...  |  read more...
USD 2,500
Global Parkinson's Disease Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... GlaxoSmithKline plc, Novartis AG and Teva Pharmaceutical Industries Ltd. Other prominent vendors in this market are: Abbvie Inc., Akorn Inc., Astellas Pharma Inc., Desitin Arzneimittel GmbH, Endo International plc, F. Hoffmann-La Roche Ltd., H. Lundbeck ...  |  read more...
USD 2,500
Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... Nucleotide Polymorphism (SNP) Genotyping and Analysis Market: Affymetrix Inc., Illumina Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Douglas Scientific Llc., Fluidigm Corp., Luminex Corp., PREMIER Biosoft Intl., Promega Corp, Qiagen ...  |  read more...
USD 2,500
Pharmaceuticals and Healthcare Report - Iraq - Q3 2014
7/23/2014 | published by: Business Monitor International
... expansions in 2014, and the Ministry of Health recently awarded 18 health project contractsworth USD276mn. In addition, new restrictions aim to end the chaos in which materials have entered thecountry in previous years, targeting control ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Kuwait - Q3 2014
7/23/2014 | published by: Business Monitor International
... is likely tohave a significant impact on margins in the sector, implementation remains slow. Concern over fakegeneric drugs presents opportunities for the segment in the country, and has spurred partnershipagreements with local distributors in the ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Portugal - Q3 2014
7/23/2014 | published by: Business Monitor International
... to growth in 2015, while pharmaceuticals will not return to growth until 2019. This isbecause while Portugal exited its bailout programme in May 2014 without the need for a new financialpackage, government austerity measures are ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Qatar - Q3 2014
7/23/2014 | published by: Business Monitor International
... by the membercountries of the Gulf Co-operation Council (GCC). The unified regional pharmaceutical pricingpolicy among GCC member states will reduce medicine prices in Qatar and improve its national drugaccessibility, if implemented properly. Although the drug ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - South Africa - Q3 2014
7/23/2014 | published by: Business Monitor International
... and poised for high single-digitgrowth over the next decade. Headline Expenditure Projections Pharmaceuticals: ZAR34.01bn (USD3.52bn) in 2013 to ZAR37.53bn (USD3.51bn) in 2014; +10.3% inlocal currency terms and -0.5% in US dollar terms. Forecast broadly in ...  |  read more...
USD 1,295
SkyePharma PLC (SKP) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Divi's Laboratories Limited (DIVISLAB) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
eResearchTechnology, Inc. - Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ...  |  read more...
USD 125
Laboratorios Andromaco S.A. (ANDROMACO) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
< prev 1    3  4  5  6  7  8  9  10